Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

KalVista Pharmaceuticals (KALV) Return on Assets (2017 - 2024)

KalVista Pharmaceuticals' Return on Assets history spans 9 years, with the latest figure at 0.58% for Q4 2024.

  • For Q4 2024, Return on Assets changed N/A year-over-year to 0.58%; the TTM value through Dec 2024 reached 0.58%, changed N/A, while the annual FY2020 figure was 0.06%, 17.0% up from the prior year.
  • Return on Assets for Q4 2024 was 0.58% at KalVista Pharmaceuticals, up from 0.89% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.38% in Q1 2020 and bottomed at 0.89% in Q4 2024.
  • The 4-year median for Return on Assets is 0.6% (2020), against an average of 0.61%.
  • The largest YoY upside for Return on Assets was -7bps in 2024 against a maximum downside of -34bps in 2024.
  • A 4-year view of Return on Assets shows it stood at 0.6% in 2020, then fell by -13bps to 0.68% in 2021, then grew by 19bps to 0.55% in 2023, then decreased by -5bps to 0.58% in 2024.
  • Per Business Quant, the three most recent readings for KALV's Return on Assets are 0.58% (Q4 2024), 0.89% (Q4 2024), and 0.67% (Q3 2024).